Year: 2021

Innovations in closed-ended DNA (ceDNA) and cell-targeted lipid nanoparticle (ctLNP) production processes generated peak mean of 205% normal human factor VIII expression in miceNon-human primates (NHPs) demonstrated up to 2% normal human factor VIII expression, and higher-than-expected variability within and between studiesCompany is using insights from preclinical studies to advance additional novel proprietary ctLNPs to improve species translation to meet target profile for a development candidateCAMBRIDGE, MASS., Dec. 14, 2021 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today provided an update on factor VIII expression from a series of mouse and companion non-human primate (NHP) studies in hemophilia A,...

GATINEAU, Quebec, Dec. 14, 2021 (GLOBE NEWSWIRE) — HEXO Corp (TSX: HEXO; NASDAQ: HEXO), a leading producer of high-quality cannabis products, today announced the appointment of John K. Bell as Chair of the Board of Directors, effective December 14, 2021. “A key priority for the Company is to enhance its corporate governance and John brings a tremendous amount of experience to this role,” said Scott Cooper, President and CEO of HEXO. “John’s strong financial background and experience in the cannabis sector make him ideally suited as we move forward with our new plan to solidify our position as Canada’s leading cannabis company.” “HEXO has a strong foundation with unique capabilities and assets based on its recent acquisitions to accelerate growth and build market share,” said John Bell. “I am looking forward to working with the...

BEIJING, Dec. 14, 2021 (GLOBE NEWSWIRE) — Luckin Coffee Inc. (in Provisional Liquidation) (“Luckin Coffee” or the “Company”) (OTC: LKNCY) announced today that the Grand Court of the Cayman Islands (the “Cayman Court”) has sanctioned the scheme of arrangement (the “Scheme”) proposed by Luckin Coffee with the support of its Joint Provisional Liquidators,1 in relation to the restructuring of its $460 million 0.75% Convertible Senior Notes due 2025 (“Existing Notes”). Sanction Hearing As previously announced, following the Scheme being unanimously approved by all attending creditors (in person or by proxy) at the Scheme meeting on November, 30 2021, the hearing of the Company’s petition seeking sanction of the Scheme took place before the Cayman Court on December 13, 2021 (Cayman Islands time). The Company is pleased to announce that...

Oslo (Norway), 14 December 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced that it has been invited to present at the DNB Nordic Healthcare Conference 2021, an Oslo based online event hosted by DNB. On Thursday, 16 December 2021 at 11:10 (CET), Dr. Per Walday, CEO, will present an overview of PCI Biotech’s proprietary platform technology via a general company presentation. The Company is also available for 1:1 meetings with potential partners and investors. The presentation slides will be made available on PCI Biotech’s website (www.pcibiotech.com) under “Other presentations”. Contact information:        Per Walday, CEO        pw@pcibiotech.noMobile: +47 917 93 429 About PCI Biotech        PCI Biotech is a biopharmaceutical...

Scanfil plc        Press release 14 December 2021 at 12.00 p.m. EEST Scanfil’s Sieradz factory to go into 100% fossil-free electricity Scanfil’s Sieradz factory in Poland signed an agreement about switching to 100% fossil-free electricity. As of 1 January, 2022 Sieradz factory will be CO2 neutral in its electricity. Sieradz factory is one of Scanfil’s biggest factories and has an annual electrical energy consumption of about 3,700 MWh. If this amount of energy would be produced with coal, it would create nearly 3,850 tons of CO2 emissions. “By changing the energy source of our electricity, we can make a significant environmental impact,” states Scanfil’s Mats Lindblad, Director Quality Systems.” I am happy to see that we are moving fast and reducing our environmental impact.” Scanfil and all of its factories are committed to improving...

Figure 1.Photos from Hugin ZoneFigure 2.Map of Hugin and Neighboring ZonesVANCOUVER, British Columbia, Dec. 14, 2021 (GLOBE NEWSWIRE) — Prospect Ridge Resources Corp. (the “Company” or “Prospect Ridge”) (CSE: PRR) (OTC: PRRSF) (FRA: OED) is pleased to announce preliminary results from exploration on the Hugin zone from the recently acquired Knauss Creek property returning assays of up to 3.49 grams per tonne gold in channels over 0.73 meters, part of a larger channel that averaged 2.4 grams per tonne over 1.54 meters. The Hugin Zone is located only 5 linear-kilometers from CN Rail, with a direct line to deep water port at Kitimat, and only 1.3 kilometers away from the nearest logging roads. The Knauss Creek property is contiguous with the Holy Grail property, located on the eastern side of the...

Trial is scheduled for May 2023 WACO, Texas, Dec. 14, 2021 (GLOBE NEWSWIRE) — VoIP-Pal.com Inc. (“VoIP-Pal”, “Company”) (OTCQB: VPLM) is pleased to announce the Court in the Western District of Texas (WDTX) has granted the Joint Motion to Lift Stay and Proposed Schedule filed by the parties in Case Nos. 6:20-cv-267-ADA, 6:20-cv-269-ADA, 6:20-cv-272-ADA. Below are some of the key dates from the scheduling order. The complete litigation schedule has been posted on the Company website and can be accessed here.May 17, 2022, Markman Hearing at 9:00 a.m. May 18, 2022, Fact Discovery opens; deadline to serve Initial Disclosures per Rule 26(a) December 2, 2022, Close of Fact Discovery April 4, 2023, File Joint Pretrial Order and Pretrial Submissions (jury instructions, exhibits lists, witness lists, discovery and deposition designations);...